Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,596 | 774 | 79.8% |
| Consulting Fee | $1,469 | 2 | 8.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,020 | 1 | 6.0% |
| Education | $944.20 | 13 | 5.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $3,519 | 131 | $0 (2024) |
| ABBVIE INC. | $1,962 | 147 | $0 (2024) |
| Incyte Corporation | $1,812 | 34 | $0 (2024) |
| GENZYME CORPORATION | $1,697 | 50 | $0 (2024) |
| PFIZER INC. | $961.29 | 69 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $915.38 | 30 | $0 (2024) |
| Dermavant Sciences, Inc. | $861.41 | 32 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $708.92 | 26 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $684.25 | 36 | $0 (2024) |
| Lilly USA, LLC | $634.91 | 32 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,936 | 295 | Janssen Biotech, Inc. ($1,872) |
| 2023 | $3,741 | 185 | Janssen Biotech, Inc. ($854.90) |
| 2022 | $3,239 | 194 | GENZYME CORPORATION ($714.34) |
| 2021 | $2,113 | 116 | Regeneron Healthcare Solutions, Inc. ($446.28) |
All Payment Transactions
790 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: Immunology | ||||||
| 12/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $10.51 | General |
| Category: IMMUNOLOGY | ||||||
| 12/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.95 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: DERMATOLOGY | ||||||
| 12/17/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Inflammation & Immunology | ||||||
| 12/16/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $18.87 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: Dermatology | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $11.17 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $16.93 | General |
| Category: Dermatology | ||||||
| 12/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.38 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $23.77 | General |
| Category: Dermatology | ||||||
| 12/09/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $6.88 | General |
| Category: DERMATOLOGY | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $5.56 | General |
| 12/04/2024 | Incyte Corporation | OPZELURA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,020.00 | General |
| Category: Dermatology | ||||||
| 12/04/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $28.11 | General |
| Category: Immunology | ||||||
| 12/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.31 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $4.33 | General |
| Category: Immunology | ||||||
| 12/03/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: DERMATOLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.24 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $10.33 | General |
| Category: DERMATOLOGY | ||||||
| 12/02/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $4.00 | General |
| 11/26/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: DERMATOLOGY | ||||||
| 11/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $10.51 | General |
| Category: Immunology | ||||||
| 11/25/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $25.36 | General |
| Category: Immunology | ||||||
| 11/25/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $9.10 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 919 | 1,540 | $130,435 | $43,198 |
| 2022 | 15 | 1,452 | 2,550 | $213,568 | $74,222 |
| 2021 | 16 | 1,709 | 2,940 | $236,026 | $85,016 |
| 2020 | 13 | 974 | 1,672 | $119,141 | $40,910 |
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 232 | 265 | $36,224 | $11,544 | 31.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 156 | 187 | $18,439 | $5,784 | 31.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 90 | 97 | $16,439 | $5,717 | 34.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 83 | 83 | $14,313 | $4,619 | 32.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 74 | 79 | $11,929 | $4,113 | 34.5% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 16 | 17 | $7,657 | $2,655 | 34.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 125 | 653 | $6,280 | $2,391 | 38.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 25 | 32 | $6,359 | $2,179 | 34.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 65 | 73 | $6,182 | $2,073 | 33.5% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 30 | 30 | $3,266 | $1,052 | 32.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 12 | 12 | $2,940 | $979.38 | 33.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 12 | $404.80 | $92.40 | 22.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 324 | 400 | $53,148 | $18,468 | 34.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 137 | 165 | $27,001 | $10,066 | 37.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 150 | 163 | $24,106 | $8,612 | 35.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 231 | 286 | $27,951 | $8,456 | 30.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 138 | 138 | $22,736 | $7,992 | 35.2% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 23 | 24 | $10,605 | $4,506 | 42.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 168 | 981 | $9,476 | $3,752 | 39.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 102 | 117 | $9,651 | $3,243 | 33.6% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 76 | 76 | $8,056 | $2,344 | 29.1% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 15 | 20 | $4,886 | $1,761 | 36.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 23 | 27 | $5,063 | $1,756 | 34.7% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2022 | 18 | 19 | $6,777 | $1,545 | 22.8% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 11 | 12 | $2,211 | $829.67 | 37.5% |
About Chelsea File, PA-C
Chelsea File, PA-C is a Physician Assistant healthcare provider based in Canal Winchester, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/21/2016. The National Provider Identifier (NPI) number assigned to this provider is 1306394143.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Chelsea File, PA-C has received a total of $17,028 in payments from pharmaceutical and medical device companies, with $7,936 received in 2024. These payments were reported across 790 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($13,596).
As a Medicare-enrolled provider, File has provided services to 5,054 Medicare beneficiaries, totaling 8,702 services with total Medicare billing of $243,346. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Canal Winchester, OH
- Active Since 09/21/2016
- Last Updated 05/01/2017
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1306394143
Products in Payments
- TREMFYA (Drug) $3,149
- DUPIXENT (Biological) $2,348
- OPZELURA (Drug) $1,812
- RINVOQ (Biological) $935.00
- SKYRIZI (Biological) $920.97
- VTAMA (Drug) $861.41
- EUCRISA (Drug) $720.68
- Sotyktu (Drug) $708.92
- Otezla (Drug) $533.20
- REMICADE (Biological) $469.93
- TALTZ (Drug) $465.76
- ADBRY (Biological) $297.09
- ILUMYA (Biological) $278.26
- CIBINQO (Drug) $240.61
- AKLIEF (Drug) $238.63
- Zoryve (Drug) $231.02
- COSENTYX (Biological) $230.08
- QBREXZA (Drug) $192.59
- Winlevi (Drug) $172.71
- COSENTYX (Drug) $148.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Canal Winchester
Caitlin Lavilla
Physician Assistant — Payments: $3,410
Kristyn Haight, Pa, PA
Physician Assistant — Payments: $891.58
Bethany Sheldon, Pa-C, PA-C
Physician Assistant — Payments: $291.06
Andrew Schwall, Pa, PA
Physician Assistant — Payments: $240.87
Linda Baker
Physician Assistant — Payments: $229.55
Megan Benson, P.a, P.A
Physician Assistant — Payments: $99.55